{"transactions":[{"id":752504,"issuer":{"id":6721,"kind":"organization","name":"ONCOLYTICS BIOTECH INC"},"owners":[{"id":41895,"kind":"person","name":"Kelly Jared","position":1,"cik":"0002103581","reported_name":"Kelly Jared","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2026-06-03T20:30:29.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":755000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date."}],"balance_after":755000,"derivative":{"exercise_price":1.06,"expiration_date":"2036-06-01","underlying":"Common Shares","underlying_shares":755000},"source":{"system":"sec-edgar","filing":"0001493152-26-027084","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1129928/000149315226027084/ownership.xml","form_type":"4"}},{"id":844369,"issuer":{"id":6721,"kind":"organization","name":"ONCOLYTICS BIOTECH INC"},"owners":[{"id":41895,"kind":"person","name":"Kelly Jared","position":1,"cik":"0002103581","reported_name":"Kelly Jared","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-13T12:00:01.000Z","date":"2026-03-12","kind":"purchase","planned":false,"acquired":true,"shares":5050,"price":0.96,"value":4848.0,"ownership":{"direct":true},"balance_after":114050,"source":{"system":"sec-edgar","filing":"0001493152-26-009982","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1129928/000149315226009982/ownership.xml","form_type":"4"}},{"id":905640,"issuer":{"id":6721,"kind":"organization","name":"ONCOLYTICS BIOTECH INC"},"owners":[{"id":41895,"kind":"person","name":"Kelly Jared","position":1,"cik":"0002103581","reported_name":"Kelly Jared","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-02-13T12:00:32.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":29500,"price":0.842,"value":24839.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.820 to $0.856, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":109000,"source":{"system":"sec-edgar","filing":"0001493152-26-006545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1129928/000149315226006545/ownership.xml","form_type":"4"}},{"id":905639,"issuer":{"id":6721,"kind":"organization","name":"ONCOLYTICS BIOTECH INC"},"owners":[{"id":41895,"kind":"person","name":"Kelly Jared","position":1,"cik":"0002103581","reported_name":"Kelly Jared","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-02-13T12:00:32.000Z","date":"2026-02-11","kind":"purchase","planned":false,"acquired":true,"shares":5600,"price":0.836,"value":4681.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.820 to $0.856, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":79500,"source":{"system":"sec-edgar","filing":"0001493152-26-006545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1129928/000149315226006545/ownership.xml","form_type":"4"}}]}